Cholesterol efflux capacity predicts graft failure in renal transplant

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.
Takeaway
  • In patients undergoing renal transplant, cholesterol efflux capacity is a strong predictor of graft failure, independent of plasma HDL-C levels
Methods
  • Study population: cohort of renal transplant recipients (n=495, median follow-up: 7.0 years)
  • Cholesterol efflux capacity was quantified at baseline using incubation of human macrophage foam cells with apolipoprotein B-depleted plasma
Results
  • No difference in baseline efflux capacity between deceased patients and survivors (P=.60  for cardiovascular mortality; P=.50 for all-cause mortality)
  • Lower efflux capacity in patients with graft failure vs patients with functioning grafts (P<.001)
  • Baseline efflux capacity significantly predicted graft failure (HR, 0.43; 95% CI, 0.29 to 0.64; P<.001) independent of apolipoprotein A-I, HDL cholesterol, or creatinine clearance